Page last updated: 2024-10-18

dihydroxyphenylalanine and Glomangioma

dihydroxyphenylalanine has been researched along with Glomangioma in 2 studies

Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hoegerle, S1
Ghanem, N1
Altehoefer, C1
Schipper, J1
Brink, I1
Moser, E1
Neumann, HP1
Marsch, WC1
Ernst, TM1
Artuc, M1
Stüttgen, G1

Trials

1 trial available for dihydroxyphenylalanine and Glomangioma

ArticleYear
18F-DOPA positron emission tomography for the detection of glomus tumours.
    European journal of nuclear medicine and molecular imaging, 2003, Volume: 30, Issue:5

    Topics: Adult; Aged; Carotid Body Tumor; Dihydroxyphenylalanine; Female; Glomus Tumor; Humans; Male; Middle

2003

Other Studies

1 other study available for dihydroxyphenylalanine and Glomangioma

ArticleYear
[Multiple generalized glomus tumors. Morphologic and biochemical findings].
    Zeitschrift fur Hautkrankheiten, 1986, Jun-15, Volume: 61, Issue:12

    Topics: Cyclic AMP; Dihydroxyphenylalanine; Female; Glomus Tumor; Hemangioma, Cavernous; Humans; Middle Aged

1986